Now livetag icon
What will define the 2026 holiday season? 🔎 See how shoppers are deciding. Download the reportbanner icon
HORMOSAN

March 2026

HORMOSAN Market Share Analysis for March 2026

ihr pharmaunternehmen für innovative medikamente und generika. mit unserer breiten palette von innovativen medikamenten bis hin zu generika unterstützen wir die erfolgreiche behandlung von diversen akuten und chronischen erkrankungen.
Industry: N/A
Year Founded1968
Employees51 - 200
Annual Revenue$5M - $10M
hormosan.com
HORMOSAN
HORMOSAN (including company regionals)
  • hormosan.com
    hormosan.com
See more website traffic and engagement information

HORMOSAN Revenue up to March 2026 is 5M - 10M

revenue generated by HORMOSAN top domains

HORMOSAN top domains revenue over 3 years

Revenue for HORMOSAN top domains


Total visits to HORMOSAN's top domains

Understand HORMOSAN market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

Avg. visit duration in HORMOSAN's top domains

Analyze HORMOSAN engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

Avg. pageviews on HORMOSAN's top domains

See how HORMOSAN keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

Want to gain deeper traffic insights?

Filter 20.3M+ online businesses. Discover new leads when their traffic spikes, when they start or stop using technologies, or when they get positive press.



Top technologies used by HORMOSAN

These are the website technologies, by industry, used by HORMOSAN top domains

Conversion & Analytics (2)

Google Analytics

Google Analytics

Mobile (2)

Meta Viewport

Meta Viewport

Email Services (1)

1 and 1 Email Hosting

1 and 1 Email Hosting

Payment & Currencies (1)

Euro

Euro

More Technologies

1

See all

Ready to discover high quality prospects?

Identify what technologies a website uses to craft the perfect sales pitch, and shorten the sales cycle with the Similarweb Sales Intelligence Solution.


News & Signals from HORMOSAN

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsHormosan Pharma GmbH launches Luforbec beclometasone / formoterol MDI.Lupin announced that its German subsidiary Hormosan Pharma has launched Luforbec beclometasone / formoterol MDI for the treatment of asthma and COPD in Germany.
NewsHormosan Pharma GmbH launches Luforbec in the European nation.Hormosan Pharma GmbH, a wholly-owned subsidiary of the company in Germany, has introduced Luforbec in the European nation, Lupin said in a statement.
NewsHormosan Pharma GmbH launches Luforbec 100/6.Mumbai: Hormosan Pharma GmbH (Hormosan), Lupin’s wholly-owned subsidiary in Germany, announced the launch of Luforbec 100/6 (beclometasone 100 µg / formoterol 6 µg), a fix combination in a pressurised metered dose inhaler (pMDI) for the treatment of adult asthma and chronic obstructive pulmonary disease (COPD) in Germany.

See all HORMOSAN signals

Focus your sales teams on the most promising opportunities. By prioritizing opportunities and engaging at the right time, you can optimize efforts and close more deals.